Abstract
Background Population-representative household survey methods require up-to-date sampling frames and sample designs that minimize time and cost of fieldwork especially in low- and middle-income countries. Traditional methods such as multi-stage cluster sampling, random-walk, or spatial sampling can be cumbersome, costly or inaccurate, leading to well-known biases. However, a new tool, Epicentre’s Geo-Sampler program, allows simple random sampling of structures, which can eliminate some of these biases. We describe the study design process, experiences and lessons learned using Geo-Sampler for selection of a population representative sample for a kidney disease survey in two sites in Guatemala.
Results We successfully used Epicentre’s Geo-sampler tool to sample 650 structures in two semi-urban Guatemalan communities. Overall, 82% of sampled structures were residential and could be approached for recruitment. Sample selection could be conducted by one person after 30 minutes of training. The process from sample selection to creating field maps took approximately 40 hours.
Conclusion In combination with our design protocols, the Epicentre Geo-Sampler tool provided a feasible, rapid and lower-cost alternative to select a representative population sample for a prevalence survey in our semi-urban Guatemalan setting. The tool may work less well in settings with heavy arboreal cover or densely populated urban settings with multiple living units per structure. Similarly, while the method is an efficient step forward for including non-traditional living arrangements (people residing permanently or temporarily in businesses, religious institutions or other structures), it does not account for some of the most marginalized and vulnerable people in a population—the unhoused, street dwellers or people living in vehicles.
Competing Interest Statement
Alexandre Blake worked for Epicentre on the Geo-Sampler tool between 2015 and 2018. Francesco Grandesso works for Epicentre. The authors declare no other competing interests.
Funding Statement
This study was funded via the National Institutes of Health R21 grant FIC R21 TW010831-02: Building capacity for chronic kidney disease research in Guatemala (Peter Rohloff, PI; Carlos Mendoza co-PI)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a methods paper, and as such, does not require IRB review. The main study on which is it based (not the subject of this manuscript) has been reviewed and approved by the Institutional Review Boards of Maya Health Alliance (WK 2018 001), the Institute for Nutrition of Central American and Panama (CIE REV 075/2018) and Partners Healthcare (2017P002476).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Datasets created for this manuscript are not publicly available because they are coordinates of specific structures and residences of study participants; these data will not be made public for confidentiality reasons. However, a deidentified replication dataset from the entire study (Chronic Kidney Disease of unknown etiology) will be made available at the Principal Investigator's Harvard University's Dataverse following publication of final study results.
List of Abbreviations
- CKD
- Chronic Kidney disease
- CKDu
- Chronic Kidney Disease of unknown etiology
- DHS
- Demographic and Health Surveys
- EPI
- Expanded Programme on Immunization
- GPS
- Geographic positioning system
- KDIGO
- Kidney Disease: Improving Global Outcomes
- LMIC
- Low- and middle-income countries
- LPN
- Licensed practical nurse
- MICS
- Multiple Indicator Cluster Surveys
- NIH
- National Institutes of Health
